The extracellular matrix (ECM) contains rich biological cues for cell recruitment, proliferationm, and even differentiation. The osteoinductive potential of scaffolds could be enhanced through human bone marrow mesenchymal stem cell (hBMSC) directly depositing ECM on surface of scaffolds. However, the role and mechanism of human umbilical cord mesenchymal stem cells (hUCMSC)-secreted ECM in bone formation remain unknown. We tested the osteoinductive properties of a hUCMSCsecreted ECM construct (hUCMSC-ECM) in a large femur defect of a severe combined immunodeficiency (SCID) mouse model. The hUCMSC-ECM improved the colonization of endogenous MSCs and bone regeneration, similar to the hUCMSC-seeded scaffold and superior to the scaffold substrate. Besides, the hUCMSC-ECM enhanced the promigratory molecular expressions of the homing cells, including CCR2 and TβRI. Furthermore, the hUCMSC-ECM increased the number of migrated MSCs by nearly 3.3 ± 0.1-fold, relative to the scaffold substrate. As the most abundant cytokine deposited in the hUCMSC-ECM, insulin-like growth factor binding protein 3 (IGFBP3) promoted hBMSC migration in the TβRI/II-and CCR2-dependent mechanisms. The hUCMSC-ECM integrating shRNA-mediated silencing of Igfbp3 that down-regulated IGFBP3 expression by approximately 60%, reduced the number of migrated hBMSCs by 47%. In vivo, the hUCMSC-ECM recruited 10-fold more endogenous MSCs to initiate bone formation compared to the scaffold substrate. The knock-down of Igfbp3 in the hUCMSC-ECM inhibited nearly 60% of MSC homing and bone regeneration capacity. This research demonstrates that IGFBP3 is an important MSC homing molecule and the therapeutic potential of hUCMSC-ECM in bone regeneration is enhanced by improving MSC homing in an IGFBP3-dependent mechanism. K E Y W O R D S bone formation, endogenous MSC, human umbilical cord MSC-secreted ECM, IGFBP3, recruitment 5792 | wileyonlinelibrary.com/journal/jcp
| INTRODUCTION
Large bone defect is a challenge confronting orthopedic surgery.
Autologous bone transplantation is the gold standard for bone defect healing, but its availability is limited because of significant comorbidities (Boden, 2000) . Bone graft materials with high osteoinductive potentials are the key of large bone defects healing.
Tissue engineered technology improves the osteoinductive potential of scaffolds through seeding mesenchymal stem cells (MSCs) on surface of scaffolds (Henkel et al., 2013; Nguyen & Burg, 2015) .
MSCs secret and deposit substantial quantities of extracellular matrix (ECM) during in vitro culture and ECM modifies the surface of scaffold substrates through decellularizing tissue engineered constructs (Decaris, Mojadedi, Bhat, & Leach, 2012; Harvestine et al., 2016) . The MSC-secreted ECM allows bypassing of living MSCinduced clinical limits including long-time storage, economic, and logistic issues (Martin, 2014; Meijer, de Bruijn, Koole, & van Blitterswijk, 2007) .
ECM is comprised of rich biological proteins for directing cell fate. Some studies show that human bone marrow MSC-secreted ECM constructs induce osteogenesis (Bourgine et al., 2014a; Deng et al., 2016; Harvestine et al., 2016; Sutha et al., 2015; Zhou et al., 2016) . However, the acquisition of human bone marrow MSCs (hBMSCs) is an invasive approach and the isolation is limited to the nutritional status and age of donors. For the clinical application of ECM constructs, hBMSC is not a best source of MSC. MSCs isolated from human umbilical cord (hUCMSCs), which is routinely discarded as clinical waste, has the similar capacities of cell proliferation, differentiation and immunosuppression to human bone marrow MSCs (Ennis, Gotherstrom, Le Blanc, & Davies, 2008; Ullah, Subbarao, & Rho, 2015) . hUCMSC has been demonstrated to be a promising alternative source of MSC (Hou et al., 2009; Klontzas, Kenanidis, Heliotis, Tsiridis, & Mantalaris, 2015; Marupanthorn, Tantrawatpan, Kheolamai, Tantikanlayaporn, & Manochantr, 2017) . However, the role and mechanism of the hUCMSCsecreted ECM constructs (hUCMSC-ECM) on bone formation remain unknown in vivo. The hUCMSC-ECM has been demonstrated to retain a variety of cytokines secreted from hUCMSC, including insulin-like growth factor binding protein 3 (IGFBP3) which is the most abundant cytokine deposited in the hUCMSC-ECM (Deng et al., 2016) . IGFBP3 belongs to the IGF binding protein family (IGFBPs) and is a major protein binding with circulating IGF-I /II, which is the most abundant IGFBP in bone tissue (Baxter, 2013; Bhattarai, Lee, Lee, Park, & Yi, 2015; Firth & Baxter, 2002) . Some studies have demonstrated that IGFBP-3 controls cell apoptosisand survival-related functions on cancer cells (Galluzzi et al., 2012; Johnson & Firth, 2014) . In addition, IGFBP3 recruits a variety of resident cells toward injury sites, including hematopoietic stem cells/endothelial precursor cells and hepatic stellate cells (Chang et al., 2007; Kielczewski et al., 2009; Mannaerts et al., 2013) . The role of IGFBP3 from hUCMSC-ECM on the recruitment of MSC remains unclear. Recruitment of enough endogenous MSCs is the first stage in situ tissue regeneration (Vanden Berg-Foels, 2014). If IGFBP3 is an MSC homing molecule, it is logical to assume that IGFBP3 might play an important role in the hUCMSC-ECM recruiting endogenous MSCs to initiate bone formation.
In this study, we estimated bone formation of hUCMSC-ECM in vivo using a 2-mm severe combined immunodeficiency (SCID) mouse femur defect model compared to hUCMSC-seed scaffold (Vital) and the scaffold substrate (DBM). Next, we analyzed the promigratory signaling pathway and relative molecule of homing cells recruited by hUCMSC-ECM in vivo, and investigated the promigratory signaling pathway of hUCMSC-ECM on hBMSCs in vitro. Finally, we demonstrated that hUCMSC-ECM could recruit resident MSCs to initiate bone formation by IGFBP3 signaling pathway in vivo.
| MATERIALS AND METHODS

| Culture of cells and preparation of scaffolds
The protocols for isolating hUCMSCs and hBMSCs were as reported previously (Deng et al., 2016) . MSCs were cultured in DMEM/F12 (HyClone, GE Healthcare life sciences, UT) with 10% fetal bovine serum (FBS; Gibco by life technologies corporation, NY), 0.1% penicillin, and streptomycin. The identification of MSCs was conducted on the basis of the criteria established by International Society for Cellular Therapy (ISCT) and assessed with using the human MSC Analysis Kit (562245, BD Biosciences, NJ) (Dominici et al., 2006; Squillaro, Peluso, & Galderisi, 2016) . Passage 3-5 hUCMSCs were used for the preparation of scaffolds. Passage 3-5 hBMSCs were used for the cell migration experiments, qPCR, and Western blot.
Demineralized bone matrix (DBM) (10 × 5 × 5 mm) was prepared with ox cancellous bone as previously described (Hou et al., 2010) . After pretreatment of DBM scaffolds in DMEM/F12 medium overnight, hUCMSCs were seeded onto DBMs at 1 × 10 6 cells/scaffold to prepare the Vital. The Vital were further cultured in complete medium for 14 days, rinsed with PBS, flash frozen in liquid nitrogen for 10 min, thawed in a 37°C water bath with shaking at 60 rpm for 20 min, rinsed with PBS, frozen at −80°C overnight, and freeze-dried to prepare the hUCMSC-ECM. For the graft transplant to the SCID mice femur defect, DBM (3 × 3 × 3 mm, seeded with 4 × 10 4 cells/scaffold), were used to prepare the Vital and the hUCMSC-ECM.
To study the role of IGFBP3 from the hUCMSC-ECM on cell migration, the hUCMSC-ECM with an Igfbp3 knock-down model was used in this study. The short hairpin RNA transfection was conducted in hUCMSCs. hUCMSCs were cultured in DMEM/F12 medium containing Igfbp3 shRNA (lenti-650004YY2502, OBIO technology co.LTD, Shanghai, China) for 24 hr, and then culture medium was changed into complete culture medium containing 2.5 pM puromycin amino nucleoside (Sigma, Saint Louis, MO) to eliminate the untransfected cells. The transfected cells were used to prepare the shIgfbp3 hUCMSC-ECM (shIgfbp3) and a non-silencing shRNA as a control (shCtrl). DENG ET AL. | 5793
| Scanning electron microscopy (SEM) analysis
Scaffolds were fixed with glutaraldehyde, dehydrated in a gradient, and sealed with tert-butyl alcohol. The scaffolds were then sprayed with gold and examined using a scanning electron microscope (S3400N II; Hitachi, Tokugawa, Japan) with an accelerating voltage of 15 kV and a working distance of 20-60 mm.
| Cytokine quantification
Total proteins in DBM, Vital, and hUCMSC-ECM were extracted with RIPA lysis buffer containing PMSF (Beyotime, Nanjing, Jiangsu, China), Cytokine levels were measured with ELISA kits (ELH-IGFBP3-001, ELH-bFGF-001; ELH-OPG-001; RayBiotech, Norcross, GA).
| Immunofluorescent staining
For the in vitro assay, scaffolds were washed with PBS, blocked with 3% bovine serum albumin (BSA) for 30 min, and incubated overnight at 4°C with primary antibodies against IGFBP3 (1:50, rabbit anti-human, Santa Cruz) in addition to 2U of Rhodamine Phalloidin (Biotium, Hayward, CA); DAPI was used to stain nuclei.
For the in vivo assay, the scaffolds, retrieved at 7 days in vivo, were embedded in optimal cutting temperature compound, and snap frozen at −20°C. Sections (8 µm thick) were incubated overnight at 4°C with primary antibodies against Sca-1 (1:500, 7 H4 L3, Invitrogen, CA) and PDGFR-α (1:500, Invitrogen). Secondary antibody labeled with Alexa Fluor 488 (1:100, donkey anti-rabbit) or Cy3 (1:100, goat anti-rat, ZSGB-BIO, Beijing, China) were used as appropriate. DAPI was used to stain nuclei. The number of Sca-1 + PDGFR-α + cells were counted and the percentage of Sca-1 + PDGFR-α + cells to the total cells were determined Fluorescence images were acquired using a Two Photon Laser Scanning System (LSM 510 NLO, Zeiss, Oberkochen, Germany).
A total of three images per animal distributed within the defect area, with 800× magnification, were analyzed.
| Cell migration
The migration assay was carried out according to the methods published in our previous study (Deng et al., 2016) . Briefly, 1.5 × 10 4 hBMSCs in 100 µl of serum-free culture medium were placed in the upper chambers of 24-well Transwell plates (8 mm, Millipore, Darmstadt, Germany). The different concentrations of IGFBP3 or scaffolds (DBM, shIgfbp3, or shCtrl) were added in the lower wells with 1 ml of culture medium. For inhibition of the promigratory signaling pathway, hBMSCs were pretreated with 2 µM of SB505124 (for TβR I/II signaling pathway; Sellleckchem.cn, China), 500 nM BMS CCR2 22 (for CCR2 signaling pathway; Minneapolis, MN) for 1 hr prior to cell seeding. After 24 hr of incubation, the nonmigrated cells to the lower side of the filter were removed with cotton swabs, while the migrated cells were fixed with 4% paraformaldehyde and stained with crystal violet. The number of migrated cells was counted in three different fields under a microscope at 100× magnification. The data were averaged from three parallel experiments.
| Quantitative real-time polymerase chain reaction
For the in vitro experiment, the expression of receptor genes related to cell migration (PDGF-Rα, PDGF-Rβ, CCR4, IGF1R, TβR I, CCR2, and CXCR4) was examined by quantitative PCR. Briefly, for the in vitro experiment, hBMSCs were collected after 1, 2, and 3 days of incubation in culture media containing 25 ng/ml IGFBP3 (Peprotech, Rocky Hill, NJ), respectively. For the in vivo experiment, the expression of receptor genes related to cell migration (TβR I and CCR2) was examined. The tissue from scaffolds (DBM, shCtrl, and shIgfbp3) were collected at day 7 post implantation.
Total RNA was extracted with TRIzol reagent (Invitrogen, Waltham, MA) and reverse transcribed with the PrimeScript™ RT reagent kit (Takara, Shimogyo-ku, Kyoto, Japan) according to the manufacturer's instructions.
Real-time PCR was performed using 2 × SYBR Green PCR Master Mix Biosystems 7500). All the primer sequences (Sangon Biotech Co., Ltd., Shanghai, China) were designed using primer 5.0 software and these sequences are summarized in Supplemental Table S1 . 
| RNA sequencing
| Dif-gene-finder
We applied DESeq algorithm (Anders & Huber, 2010 ) to filter the differentially expressed genes, after the significant analysis, p-value and FDR analysis under the following criteria (Benjamini, Drai, Elmer, Kafkafi, & Golani, 2001) , mRNA under the following criteria: (i) Fold Change >2 or <0.5 and (ii), FDR <0.05.
| Pathway analysis
Pathway analysis was used to find out the significant pathway of the differential genes according to KEGG database. We turn to the Fisher's exact test to select the significant pathway, and the threshold of significance was defined by p-value and FDR.
| Western blotting
To analyze the effects of IGFBP3 on the promigratory signaling pathway, hBMSCs were treated with culture medium containing 25 ng/ml IGFBP3 with or without pretreatment with 2 µM of SB505124 for inhibition of TβR I/II or p-Smad 2/3, 500 nM BMS CCR2 22 for inhibition of CCR2. The hBMSCs were collected with or without IGFBP3 treatment for 6 hr, 12 hr, 1, 2, and 3 days, respectively. Total protein was extracted with 100 µl RIPA lysis buffer (P0013B, Beyotime, Jiangsu, China), subjected to SDS-PAGE, transferred on nitrocellulose membranes (Millipore, Billerica) and probed with specifics primary antibodies against p-Smad 2/3 (Cell Signaling Technology), Smad 2/3(Santa Cruz Biotechnology, Texas), CCR2 (Santa Cruz Biotechnology) or TβR I/II (Santa Cruz Biotechnology), or GAPDH (Beyotime, Jiangsu, China) at 1: 500 dilution overnight at 4°C. Immunoreactive protein bands were visualized using ECL chemiluminescence detection plus a Western blot detection system (Bio-Rad). The intensity ratio was the relative expression of p-Smad2/3, Smad 2/3, TβR I, TβR II, and CCR2 normalized to GAPDH. 
| Animal surgical procedures and experimental design
| Flowcytometry
At 3, 7, 10, and 14 days postoperatively, the scaffolds were collected, cut into small pieces, and placed in a centrifuge tube. 
| Histology assessment
The femurs were retrieved. The muscle and soft tissue were stripped off. Next, the scaffolds or regenerated tissue were fixed in 4% buffered paraformaldehyde, decalcified in 50 mmethylenediaminetetraacetic acid, embedded in paraffin and sectioned at 4-6 mm thickness. The slides were used for H-E staining.
| Statistical analysis
One-way ANOVA followed by Tukey's test was utilized to determine the statistical significance of the differences inimmunofluorescent staining and cell migration. Two-way ANOVA followed by Sidak's multiple comparisons test was performed to determine the statistical significance of the real-time PCR, WB, flow cytometry, and Micro CT data. EB-seq was used for Dif-Gene-Finder and Fisher's exact test was used to select the significant pathway. The results are displayed as the mean stand ±standard deviation for n ≥3 scaffolds per group in all cases, unless otherwise indicated. For all the statistical tests, differences were considered to be significant if p < 0.05.
| RESULTS
| Osteoinductive property of the hUCMSC-ECM was similar to the Vital and superior to scaffold substrate
First, we tested whether the hUCMSC-ECM was capable of inducing bone regeneration (Deng et al., 2016) . The hUCMSCs isolated from umbilical cord Wharton's Jelly were identified and shown the characteristics of MSCs (Supplemental Figure S1 ). Primary hUCMSCs were seeded on DBM and cultured for 2 weeks in complete culture medium (DBM, Vital; Figures 1a and 1b) . The hUCMSC-ECM successfully displayed scaffolds surrounded by a protein-rich surface (hUCMSC-ECM; Figure 1a ). The hUCMSC-ECM was positively stained for IGFBP3, but not for cell components (F-actin with red staining was not observable; Figure 1b ). Quantitative assessments indicated that the loss of the principal cytokine amount was less than 1/3 amount of Vital, including IGFBP3 (−12.7%), bFGF (non significant difference), and OPG (−31.3%) (Figure 1c) .
A large femur defect model of SCID mice was used to assess osteoinductivity of scaffolds (Figure 1d ). The colonization of host cells was evident in the Vital and, to a lower extent, in the hUCMSC-ECM, and DBM were colonized by a few resident cells (blue DAPI staining, Figure 1e ). The homing MSCs (cells co-labeling with green Sca-1 staining and red PDGFR-α staining) in the Vital and hUCMSC-ECM groups were more than those in DBM group (p < 0.05 for the Vital or hUCMSC-ECM groups vs. the DBM group, Figure 1f ). Defects in the Vital group and the hUCMSC-ECM group were extensively regenerated, resulting in interconnected mineralized bone trabeculae Figure 1g ). In contrast, the retrieved DBM maintained less bone formation and showed a clear defect gap (Figure 1g ). Quantitative analysis of micro-CT at 4 weeks post implantation showed BV/TV, Tb.N, and BMD of the regenerated bone in hUCMSC-ECM were 10.2 ± 3.2-, 6.9 ± 2.4-, and 8.4 ± 3.4-fold higher than those of DBM, respectively, which indicated that hUCMSC-ECM remained superior to DBM (p < 0.05, Figure 1h ). There was no difference between the Vital and hUCMSC-ECM in BV/TV, Tb.N, and BMD, indicating that the hUCMSC-ECM had the same bone formation capacity as the Vital (Figure 1h ).
| The hUCMSC-ECM upregualted the pro-migratory gene expression and hBMSC migration
Besides osteoinductive capacity, the osteoinductive mechanism of the hUCMSC-ECM has attracted most scientific interest. The osteoinductivity of ECM has been considered relying on a mixture of factors accumulated at doses within physiological ranges (Bourgine et al., 2014a) . This is not a specific mechanism, but just a popular recognition. Recent some successful proof-of-concept studies confirm that the first stage of in situ tissue regeneration must result in recruitment of endogenous MSCs and cells (Vanden Berg-Foels, 2014). Figure 1e had shown that more host cells were colonized in the hUCMSC-ECM than DBM (blue DAPI staining, Figure 1e ). Furthermore, transcriptome analysis of promigratory genes significantly upregulated in homing cells collected from the hUCMSC-ECM was conducted compared to DBM. The enrichment analysis of pathways demonstrated eight pathways were significant(p < 0.01) and the dominant pathway related to cell migration was the cytokinecytokine receptor in interaction signaling pathway, enriching more than 30 cytokine receptors which included many CCRs and CXCRs cytokine receptors (Àlog 10 p ¼ 10:04) (Figure 2a ). Besides, NF-κβ signaling pathway (Àlog 10 p ¼ 7:51), NOD-like receptor signaling pathway (Àlog 10 p ¼ 5:11), and TGFβ signaling pathway (Àlog 10 p ¼ 4:50), paid an important role on cell homing (Figure 2a ). Among the upregulated 89 genes being coincident in the significant promigratory pathways, seven differentially-expressed genes of ECM group upregulated more than fivefolds than that of DBM group, shown in the heatmap (Figure 2b and supplemental Figure S2 ). The seven genes included CXCR1, an important regulator of vascular endothelial cell migration, TGFβ1, and CCR2, the pro-migratory receptors of MSCs (Ponte et al., 2007; Wan et al., 2012; Zeng, Shen, Huang, Liu, & Liu, 2012) .
Stem cell migration is the first step of cell recruitment (Vanden
Berg-Foels, 2014). Prompted by the immunofluorescence results that more host MSCs were colonized in hUCMSC-ECM on 3-14 days post implantation, we investigated whether hUCMSC-ECM played a positive role in MSCs migration in vitro. After 10-hr stimulation, the number of migrated hBMSC in hUCMSC-ECM group was 3.3 ± 0.1-fold higher than that of DBM groups (p < 0.001; Figure 2c ).
| IGFBP3 promoted the migration of hBMSCs
The mode of recruitment is directional migration in response to a gradient of soluble chemoattractants, including growth factors (GFs) and chemokines(Lairdvon, von Andrian, & Wagers, 2008). In a previous study, quantitative cytokine array analysis showed that the amount of IGFBP3, the principal component in hUCMSC-ECM, accounted for 23% of the total amount of 56 cytokines tested (Deng et al., 2016) .
Furthermore, IGFBP3 could stimulate the migration of hematopoietic stem cells (Kielczewski et al., 2009; Ponte et al., 2007) . We therefore evaluated the role of IGFBP3 in hBMSC migration. A Transwell assay showed that hBMSCs migration was correlated with the concentration of IGFBP3. When its concentration was not higher than 25 ng/ml, IGFBP3 promoted hBMSCs migration in a concentration-dependent manner. At 25 ng/ml of IGFBP3, the number of migrated cells reached a peak and was nearly 1.5 ± 0.1-fold higher than in the vehicle control.
In contrast, at the concentration of IGFBP3 higher than 25 ng/ml, IGFBP3 inhibited cell migration (p < 0.001, Figure 2d ).
| IGFBP3-induced hBMSC migration required the activation of the TGFβ and CCR2 signaling pathways
The promigratory activity of IGFBP3 on hBMSCs has rarely been reported and the acting signaling pathway of IGFBP3 is of interest. In contrast to HSCs, whose migration is induced mainly by SDF-1, the migratory capacity of MSCs could be affected by various chemotactic factors and receptors (Ponte et al., 2007) . López Ponte et al. (2007) reported that some membrane receptors were particularly relevant for adult bone marrow MSC homing, such as PDGF-Rβ, PDGF-Rα, IGF-1R, CCR2, CCR4, and CXCR4. Furthermore, the TGFβ signaling pathway was demonstrated to be associated with IGFBP3-induced migration of hepatic stellate cells (Mannaerts et al., 2013) . Thus, we evaluated the roles of IGFBP3 on the above mentioned receptors.
qPCR results showed that the relative expression of PDGF-Rβ, PDGF-Rα, IGF-1R, and CXCR4 in the IGFBP3 group decreased heavily compared to those of the vehicle group (p < 0.001; Figure 3a) .
Meanwhile, the expressions of CCR2 and TβRI in the IGFBP3 group were nearly 5.6 ± 0.7-and 5.5 ± 0.5-fold higher than those in the vehicle group, respectively, at day 2 of stimulation (p < 0.001; Figure   3a ). There was no difference in the expression of CCR4 between the IGFBP3 and vehicle groups (Figure 3a) . were evaluated. After pretreatment with inhibitors, the IGFBP3induced relative expressions of CCR2, TβRI and pSmad 2/3 decreased by 56.7 ± 5.6%, 82.1 ± 6.2%, and 73.3 ± 2.9%, relative to the vehicle group, respectively (p < 0.005 for CCR2 and p < 0.001 for TβRI and pSmad 2/3; Figure 3e-g) . Accordingly, the number of IGFBP3-induced migrated cells decreased by 33.2 ± 6.3% and 43.3 ± 5.5% for the inhibition of the TβRI/II pathway and CCR2 pathway, respectively (p < 0.001, Figure 4 ).
| hUCMSC-ECM induced the chemotaxis of hBMSCs by the IGFBP3 signaling pathway
To investigate the roles of IGFBP3 on the hUCMSC-ECM-induced migration of hBMSCs, we prepared the hUCMSC-ECM with a knock down of Igfbp3 and observed whether the migratory ability of hBMSC was inhibited when IGFBP3 signaling was blocked. After 14 days of culture, the relative expression of IGFBP3 in the shIgfbp3 group was 40.2 ± 8.6% of that in the shCtrl group, suggesting a significant decrease of IGFBP3 expression in the shIgfbp3 group (p < 0.01; Figure 5a ). The relative expressions of CCR2, TβRI, and pSmad2/3 in the shCtrl group increased 83.3 ± 12.3%, 341.6 ± 29.0%, and 205.6 ± 14.3% compared to those of the DBM group, respectively.
However, those in the shIgfbp3 group decreased 35.5 ± 3.5%, 61.6 ± 10.7%, and 31.5 ± 8.2% compared to those of the shCtrl group, respectively (Figures 5b and 5c ).This result suggested that the knock down of IGFBP3 in the shIgfbp3 blocked the activation of the CCR2
and TβRI/II signaling pathways. Accordingly, Transwell results showed that inhibition of the IGFBP3 signaling pathway also suppressed the migratory ability of hBMSCs. Compared to the DBM group, the shCtrl enhanced 196.9 ± 13.5% of the migrated cell amount, while the shIgfbp3 inhibited 47.1 ± 9.2% of the migrated hBMSC amount (p < 0.001, Figure 5d ). 
| IGFBP3 deposited in the hUCMSC-ECM recruited endogenous MSCs to initiate bone formation
To assess whether IGFBP3 from the hUCMSC-ECM could promote the recruitment host MSCs, DBM, the shCtrl, and the shIgfbp3 were implanted into femur defects of SCID mice. Flowcytometry was used to quantify the homing of MSCs. At 3, 7, 10, and 14 days post implantation, MSCs collected from scaffolds were stained with Mouse CD45, Sca-1and PDGFR-α (Houlihan et al., 2012) . The settings of these gates refer to the study of Houlihan et al. (2012) (Supplemental Figure S3 ). Representative Sca-1 versus PDGFR-α and peaked at 7 days (2.6 ± 0.5%). Collectively, the shCtrl recruited more host MSCs than DBM did at day 3 (10.6 ± 1.7-fold more than DBM) and the knock down of IGFBP3 led a remarkable decrease of MSCs (−62.9 ± 3.8%; p < 0.001, Figure 6a ). The data indicated the successful recruitment of the host MSCs by the shCtrl, but not by DBM or the shIgfbp3, which is a prerequisite for bone regeneration.
Similar to the changes of different scaffolds-induced endogenous MSC homing, the expressions of TβRI, and CCR2 were increased by shCtrl administration by 10.7 ± 2.5-and 7.3 ± 1.5-folds, and followed by the inhibition of the shIgfbp3 by 51.5 ± 6.5% and 44.3 ± 5.2%, respectively (DBM vs. shCtrl for p < 0.001, shCtrl vs. shIgfbp3 for p < 0.01; Figure 6b ).
The presence of new bone regeneration was used to estimate whether ECM-induced host homing could initiate bone formation.
Remarkably, the shCtrl, in strong contrast to DBM and the shIgfbp3, gave rise to bone structures at 4 weeks post implantation (Figure 6c ).
After segmentation of micro-computerized tomography images, the amount of mineralized tissue was quantified. BV/TV, Tb.N, and BMD of the shCtrl group were highest, followed by the shIgfbp3 ones, whereas those of DBM group were the least (p < 0.01 for the shCtrl vs. the shIgfbp3 in BV/TV and BMD; p < 0.001 for the shCtrl vs. the shIgfbp3 in Tb.N; Figure 6d ). The BV/TV, Tb.N, and BMD of the shIgfpb3 specimens were approximately 48.3%, 35.5% and 60.4% of the shCtrl ones at week 4, respectively. The results that the shIgfpb3 resulted in inferior bone regeneration which might be attributed to the fact that the shIgfbp3 recruited less homing MSCs, while the IGFBP3 signaling pathway played a significant role in the shCtrlinduced osteogenesis (Figure 6d ). H-E histology showed that defects of DBM were filled by a layer of fibrous connective tissue, whereas woven bone filled in the defects of the shCtrl and a little new osteoid tissue was observed in the shIgfbp3 specimens at 4 weeks post implantation. After 8 weeks, the shCtrl specimens had a bony bridging of the defects with bone marrow tissue, while the shIgfbp3 specimens still were filled with cancellous bone and DBM had much less bone tissue (Figure 6e ). (Bourgine et al., 2014b) . In our previous study, IGFBP3, bFGF, and OPG deposited in hUCMSC-ECM were the three most abundant cytokines among 56 cytokines tested (Deng et al., 2016) . In the present study, the three cytokines, which have been reported to be involved in cell migration, proliferation, angiogenesis, and bone formation, accumulated more than 100 ng/cm 3 in the hUCMSC-ECM (Figure 1c ) (Baxter, 2013; Bhattarai et al., 2015; Lee, Lee, Cho, Kim, & Shin, 2015; Wang, Huang, Pan, Jiang, & Liu, 2010) . The loss of these cytokine contents in the hUCMSC-ECM was less than 30% compared to the living cells did.
Thus, the microtomographic analysis showed the regenerated bone induced by the hUCMSC-ECM was not significantly different from the Vital ones (Figure 1g ).
MSC are recruited to locations in adult tissues mainly by migration through the vascular network (Vanden Berg-Foels, 2014).
The mode of recruitment used in tissue regeneration is chemotaxis, which is directional migrationin response to a release of chemoattractants including GFs and chemokines (Vanden Berg-Foels, 2014). Although IGFBP3 is reported to recruit endothelial precursor cells and hepatic stellate cells, the role of IGFBP3 on MSC homing is still unclear (Kielczewski et al., 2009; Mannaerts et al., 2013) . In the present study, Transwell data suggested that exogenous IGFBP3 remarkably improved hBMSC migration in a dose-dependent manner ( Figure 2b) 5a and 5d; 6a and 6c) . These data showed that IGFPB3 played a decisive effect on hUCMSC-ECM recruiting MSCs to participate in bone formation. | 5801
In the previous study, the recruitment of hepatic stellate cell could be modulated by IGFBP3 through an interaction with TGFβ/Smad signaling (Mannaerts et al., 2013) . Our further study of IGFBP3 on the promigratory signaling pathway was conducted by qPCR, Western blot and Transwell assay. IGFBP3 improved hBMSCs migration through TGFβ/Smad signaling pathways, which is consistent with the reported TGFβdependent mechanism. Of note, IGFBP3-induced hBMSC migration coincided with the activation of CCR2 and CCR2 inhibitors completely blocked the IGFBP3-induced MSC migration, indicating that IGFBP3 promoted hBMSC migration through a CCR2-dependent mechanism (Figures 3 and 4) . On the other hand, genome-wide association and functional studies have shown that IGFBP3 overexpression induced cartilage catabolism and osteogenic differentiation in hip osteoarthritis (Evans et al., 2015) . Transcriptome analysis of homing cells showed that the hUCMSC-ECM significantly increased the expressions of 7 promigratory genes, including TβRI and CCR2 in vivo (Figure 2a (Figure 7 ).
In the present study, we demonstrated that the surface modification of scaffolds with hUCMSC-ECM could acquire an osteoinductive nature, similar to that of living cell-seeded material and superior to the scaffold substrate. We presented a novel mechanism of IGFBP3 signaling in the migration of hBMSCs. Lastly, this study highlights the fact that the enhanced therapeutic potential of hUCMSC-ECM by improving endogenous MSC homing in an IGFBP3-dependent manner.
